【摘要】：[目的]急性胰腺炎(Acute pancreatitis, AP)是臨床常見(jiàn)急腹癥之一。大部分急性胰腺炎為一種輕度的自限性疾病,通常不伴有并發(fā)癥。但是,仍有10%到20%的患者發(fā)展為重癥急性胰腺炎,由于劇烈的炎癥反應(yīng),造成了多臟器損傷,延長(zhǎng)了住院時(shí)間,并出現(xiàn)較高的死亡率[1]。所以判斷急性胰腺炎的嚴(yán)重程度對(duì)治療及預(yù)后的判斷有重要意義,目前臨床對(duì)急性胰腺炎嚴(yán)重程度的判斷,在臨床癥狀及影像學(xué)表現(xiàn)的基礎(chǔ)上,主要依據(jù)的指標(biāo)包括:PCT(procalcitonin)、CRP(C-reactive protein)、IL-6(Interleukin-6)等炎癥因子及相關(guān)評(píng)分標(biāo)準(zhǔn)。為了提高臨床對(duì)急性胰腺炎嚴(yán)重程度判斷的準(zhǔn)確性、高效性,可以考慮監(jiān)測(cè)PCT的同時(shí)監(jiān)測(cè)IL-6、CRP等傳統(tǒng)炎癥指標(biāo),并對(duì)比Ranson評(píng)分。另一方面,針對(duì)急性胰腺炎患者,我們應(yīng)該選擇有針對(duì)性的個(gè)體化抗生素治療(個(gè)性化抗生素管理”,Individual,Patient-adapted Antibiotic Therapy: “Antibiotic Stewardship”),以強(qiáng)化抗生素的合理應(yīng)用,減少二重感染發(fā)生。本研究將探討監(jiān)測(cè)PCT在急性胰腺炎嚴(yán)重程度評(píng)估中運(yùn)用的指導(dǎo)意義,并對(duì)比hs-CRP、IL-6以及常規(guī)白細(xì)胞計(jì)數(shù)、中性粒細(xì)胞比值等常用炎癥指標(biāo),最后評(píng)估PCT聯(lián)合hs-CRP、IL-6、Ranson評(píng)分,探索聯(lián)合監(jiān)測(cè)在急性胰腺炎嚴(yán)重程度診斷方面的意義,同時(shí)將探索動(dòng)態(tài)監(jiān)測(cè)PCT對(duì)急性胰腺炎抗生素應(yīng)用的指導(dǎo)意義。[方法]本研究采用回顧性分析方法,所有收集資料來(lái)自于昆明醫(yī)科大學(xué)第二附屬醫(yī)院的2013年7月至2016年8月診斷為急性胰腺炎的住院患者154例(女49例,男105例,年齡16-75歲)�；颊呒{入標(biāo)準(zhǔn):符合急性胰腺炎診治指南[2](2014年)診斷標(biāo)準(zhǔn)。排除標(biāo)準(zhǔn):對(duì)未診斷為急性胰腺炎,臨床資料不完整者均排除在本研究之外。入院患者收集記錄患者性別、年齡、病因等一般資料。104例AP患者根據(jù)急性胰腺炎診治指南[2](2014年)嚴(yán)重程度分級(jí)標(biāo)準(zhǔn),記錄相關(guān)數(shù)據(jù),測(cè)算Marshall評(píng)分并結(jié)合臨床證據(jù),分為輕癥急性胰腺炎(54例)、中重癥急性胰腺炎(28例)和重癥急性胰腺炎(22例)即A、B、C三組。分別于入院24小時(shí)內(nèi)采用電化學(xué)發(fā)光法法測(cè)定PCT、hs-CRP、IL-6含量,同時(shí)收集48小時(shí)內(nèi)的相關(guān)數(shù)據(jù),測(cè)算Ranson評(píng)分。再將100例中重癥及重癥急性胰腺炎患者分為:D組,動(dòng)態(tài)監(jiān)測(cè)PCT并應(yīng)用抗生素,后根據(jù)PCT數(shù)值變化判斷是否停用抗生素,中重癥急性胰腺炎和重癥急性胰腺炎患者(50例);E組,已應(yīng)用抗生素者并未動(dòng)態(tài)監(jiān)測(cè)PCT數(shù)值,經(jīng)一般常用炎癥指標(biāo)及傳統(tǒng)臨床證據(jù)(包括白細(xì)胞計(jì)數(shù)、中性粒細(xì)胞比值、體溫、心率等)指導(dǎo)判斷是否停用抗生素,中重癥急性胰腺炎和重癥急性胰腺炎患者(50例)。應(yīng)用spss19.0軟件對(duì)數(shù)據(jù)進(jìn)行統(tǒng)計(jì)分析:1.PCT、hs-CRP、IL-6、Ranson評(píng)分與急性胰腺炎嚴(yán)重程度判斷的關(guān)系;2.其對(duì)于急性胰腺炎分級(jí)診斷的價(jià)值;3.PCT、hs-CRP、IL-6、Ranson評(píng)分與急性胰腺炎嚴(yán)重程度的相關(guān)性。4.D、E兩組間抗生素使用時(shí)長(zhǎng)、住院時(shí)長(zhǎng)、抗生素單一使用或聯(lián)合使用的區(qū)別的。[結(jié)果]1.共納入患者104例,中重癥及重癥急性胰腺炎所占比例約為48%。三組急性胰腺炎患者的 PCT (中位數(shù))為{0.14(0.07,0.34) , 0.92(0.50,1.42),6.69(4.82,11.57)ng/ml}; hs-CRP 為(中位數(shù)){70.94±76.22,157.94±88.96,202.75±104.05}; IL-6 為(中位數(shù)){37.20(8.45,71.38),97.80(53.94,178.36),161.40(78.76,274.13)}; Ranson評(píng)分為(中位數(shù)){1.00(1.00,2.00), 5.00(4.00,5.00),8.00(6.75,8.00)};三組 PCT、hs-CRP、IL-6、Ranson 評(píng)分經(jīng) Kruskal-Wallis H 檢驗(yàn),三組總體差異均有明顯統(tǒng)計(jì)學(xué)意義(P 0.001)。進(jìn)一步運(yùn)用LSD法對(duì)三組hs-CRP進(jìn)行組間兩兩比較結(jié)果顯示,輕癥急性胰腺炎hs-CRP明顯低于中重癥急性胰腺和重癥急性胰腺炎組,差異均有統(tǒng)計(jì)學(xué)意義(P 0.05);但中重癥急性胰腺和重癥急性胰腺炎組hs-CRP差異無(wú)統(tǒng)計(jì)學(xué)意義(P 0.05)。運(yùn)用Mann-whitney U檢驗(yàn)對(duì)三組PCT、IL-6、Ranson評(píng)分分別進(jìn)行組間比較結(jié)果顯示,重癥急性胰腺炎組PCT明顯高于輕癥急性胰腺炎和中重癥急性胰腺組,同時(shí)中重癥急性胰腺組也明顯高于輕癥急性胰腺炎組,差異均有統(tǒng)計(jì)學(xué)意義(P 0.05)。IL-6結(jié)果與hs-CRP 一致。Ranson 評(píng)分結(jié)果與 PCT 一致。三組 CT 分級(jí)經(jīng) Kruskal-Wallis H檢驗(yàn),差異有統(tǒng)計(jì)學(xué)意義(P 0.05)。三組一般資料,包括年齡、心率經(jīng)統(tǒng)計(jì)學(xué)分析,三組總體差異有統(tǒng)計(jì)學(xué)意義(P 0.05);平均動(dòng)脈壓經(jīng)、性別差異無(wú)統(tǒng)計(jì)學(xué)意義(P 0.05)。對(duì)三組患者血液學(xué)相關(guān)指標(biāo),包括中性粒細(xì)胞比值(N%)、血鈣、白細(xì)胞(WBC)、血糖、LIPASE分別進(jìn)行統(tǒng)計(jì)學(xué)分析,三組總體差異有統(tǒng)計(jì)學(xué)意義(P 0.05),AMY三組總體差異無(wú)統(tǒng)計(jì)學(xué)意義(P 0.05)。2.共納入患者104例,中重癥及重癥急性胰腺炎所占比例約為48%。為了獲得PCT、hs-CRP、IL-6、Ranson評(píng)分四者對(duì)于診斷中重癥及重癥急性胰腺炎的精確性及臨閾值,采用受試者特征曲線(Receiver Operating Characteristic Curve,ROC)分析,結(jié)果提示四者的曲線下面積分別為:PCT (0.948±0.020)、hs-CRP (0.802±0.045)、IL-6 (0.801±0.043)、Ranson (0.980±0.014),對(duì)于中重癥及重癥急性胰腺炎的診斷閾值分別為PCT ( 0.4825ng/ml)、hs-CRP(91.69mg/l)、IL-6 (74.25pg/ml)、Ranson 評(píng)分(3.5 分),敏感性(Sensitivity,SE)(%)及特異性(Specificity,SP)(%)四者分別為:PCT(88%,88.9%)、hs-CRP(86%,70.4%)、IL-6 (72%, 77.8%)、Ranson (92%,100%)。應(yīng)用 PCT 聯(lián)合 hs-CRP兩個(gè)閾值聯(lián)合測(cè)定分析,曲線下面積為:(0.945±0.021),敏感性及特異性為:(80%,96.3%)。應(yīng)用PCT聯(lián)合Ranson評(píng)分兩個(gè)閾值聯(lián)合測(cè)定分析,曲線下面積為:(0.997±0.003),敏感性及特異性為:(100%,96.3%)。3.共納入患者104例,中重癥及重癥急性胰腺炎所占比例約為48%。PCT、hs-CRP、IL-6、Ranson評(píng)分四者與急性胰腺炎嚴(yán)重程度呈正相關(guān),結(jié)果分別為PCT (r=0.839, P 0.001 )、hs-CRP (r=0.531,P 0.001 )、IL-6 (r=0.541,P 0.001 )、Ranson 評(píng)分(r=0.879, P 0.001)。PCT、hs-CRP、IL-6、Ranson 評(píng)分四者兩兩間分析,均呈正相關(guān)。4.共納入患者100例,兩組患者年齡、性別、Ranson評(píng)分沒(méi)有統(tǒng)計(jì)學(xué)差別。D組抗生素使用時(shí)長(zhǎng)、住院時(shí)長(zhǎng)結(jié)果(均數(shù))分別為:(13.58±8.42, 15.52±6.25),E組抗生素使用時(shí)長(zhǎng)、住院時(shí)長(zhǎng)結(jié)果(均數(shù))分別為:(17.34±4.95, 22.68±6.14,天);D組、E組抗生素使用時(shí)長(zhǎng)、住院時(shí)長(zhǎng)經(jīng)兩獨(dú)立樣本t檢驗(yàn),P 0.05。兩組抗生素單一使用或聯(lián)合使用的情況經(jīng)x2檢驗(yàn),P 0.05。[結(jié)論]1.PCT、Ranson評(píng)分、CT分級(jí)可作為判斷急性胰腺炎嚴(yán)重程度分級(jí)的參考標(biāo)準(zhǔn),三者數(shù)值或分級(jí)越高提示急性胰腺炎程度越重;IL-6、hs-CRP可作評(píng)估輕型胰腺炎的參考指標(biāo)。2.對(duì)于中重癥及重癥急性胰腺炎的診斷閾值分別為PCT (0.4825ng/ml)、hs-CRP(91.69mg/l)、IL-6 (74.25pg/ml)、Ranson 評(píng)分(3.5 分);對(duì)于急性胰腺炎嚴(yán)重的診斷價(jià)值:PCT聯(lián)合Ranson評(píng)分 Ranson評(píng)分 PCT PCT聯(lián)合hs-CRP hs-CRP IL-6,說(shuō)明PCT聯(lián)合Ranson評(píng)分對(duì)中重癥急性胰腺炎和重癥急性胰腺炎的的診斷效果最好,說(shuō)明二者聯(lián)合診斷要優(yōu)于其各自診斷價(jià)值。PCT聯(lián)合hs-CRP二者聯(lián)合診斷要優(yōu)于hs-CRP診斷,次于PCT診斷。3.PCT、hs-CRP、IL-6、Ranson評(píng)分四者與急性胰腺炎嚴(yán)重程度呈正相關(guān),四者間兩兩相分析亦為正相關(guān)。4.動(dòng)態(tài)監(jiān)測(cè)PCT數(shù)值可作為指導(dǎo)中重癥和重癥急性胰腺炎抗生素治療的有效參考指標(biāo)。
[Abstract]:[Objective] Acute pancreatitis (AP) is one of the most common acute abdominal diseases. Most acute pancreatitis is a mild self limiting disease, usually without complications. However, 10% to 20% of the patients are still developing into severe acute pancreatitis. The severe inflammatory reaction caused multiple organ damage and prolonged hospitalization. And there is a high mortality rate of [1]., so it is important to judge the severity of acute pancreatitis to judge the treatment and prognosis. On the basis of clinical symptoms and imaging manifestations, the main criteria include: PCT (procalcitonin), CRP (C-reactive protein), IL-6 (Interleuk), and IL-6 (Interleuk). In-6) and other inflammatory factors and related scoring criteria. In order to improve the accuracy and efficiency of the clinical assessment of the severity of acute pancreatitis, we can consider monitoring PCT and monitoring traditional inflammatory markers such as IL-6, CRP, and compared the Ranson score. On the other hand, we should choose targeted individualized antibiotics for patients with acute pancreatitis. Treatment (individualized antibiotic management, Individual, Patient-adapted Antibiotic Therapy: "Antibiotic Stewardship") to strengthen the rational use of antibiotics and reduce the occurrence of double infection. This study will explore the guiding significance of monitoring the use of PCT in the assessment of the severity of acute pancreatitis, and compare hs-CRP, IL-6, and conventional whiteness. Cell count, neutrophils ratio and other commonly used inflammatory markers, and finally to evaluate PCT combined with hs-CRP, IL-6, Ranson score, explore the significance of joint monitoring in the diagnosis of acute pancreatitis, and explore the guiding significance of dynamic monitoring of PCT for the application of acute pancreatitis. [Methods] this study adopted a retrospective analysis, all The data were collected from 154 hospitalized patients (49 women, 105 men, 16-75 years old) diagnosed as acute pancreatitis from July 2013 to August 2016 at the Second Affiliated Hospital of Kunming Medical University. The patients were included in the criteria: guidelines for diagnosis and treatment of acute pancreatitis [2] (2014). Exclusion criteria: undiagnosed as acute pancreatitis, clinical data The patients who were incomplete were excluded from this study. The hospitalized patients collected and recorded the patient's sex, age, and etiology,.104 cases AP patients were divided into mild acute pancreatitis (54 cases) with severe acute pancreatitis (54 cases) according to the severity grading standard of acute pancreatitis, according to the severity grading standard of acute pancreatitis diagnosis and treatment guidelines (2014). 28 cases of pancreatitis (28 cases) and severe acute pancreatitis (22 cases), namely, A, B, and C three groups. The PCT, hs-CRP, IL-6 content were measured by Electrochemiluminescence Method within 24 hours of admission, and the relevant data of 48 hours were collected, and the Ranson score was measured. Then 100 cases of severe and severe acute pancreatitis were divided into D group. After the PCT numerical changes were used to determine whether to discontinue antibiotics, severe acute pancreatitis and severe acute pancreatitis (50 cases). In group E, those who had used antibiotics did not dynamically monitor the PCT values, and were guided by commonly used inflammatory markers and traditional clinical evidence (including leukocyte count, neutrophils ratio, body temperature, heart rate, etc.) No use of antibiotics, severe acute pancreatitis and severe acute pancreatitis (50 cases). The data were statistically analyzed by spss19.0 software: the relationship between 1.PCT, hs-CRP, IL-6, Ranson score and the severity of acute pancreatitis; 2. the value for the classification of acute pancreatitis; 3.PCT, hs-CRP, IL-6, Ranson score and acute pancreas The correlation of inflammatory severity was.4.D, the antibiotics used in the E two groups were long, long hospitalized, single use of antibiotics or combined use of antibiotics. [result]1. was included in 104 cases, and the proportion of severe and severe acute pancreatitis in 48%. three groups of acute pancreatitis was {0.14 (0.07,0.34), 0.92 (0.50,1.42), 6.). 69 (4.82,11.57) ng/ml}; hs-CRP is (median) {70.94 + 76.22157.94 + 88.96202.75 + 104.05}; IL-6 is (median) {37.20 (8.45,71.38), 97.80 (53.94178.36), 161.40 (78.76274.13)}; the score is (median), 5 (median), 8 (8)}; three groups S H test, the total difference between the three groups had significant statistical significance (P 0.001). Further use of LSD method to compare 22 groups of three groups of hs-CRP showed that the hs-CRP of mild acute pancreatitis was significantly lower than that of severe acute pancreatitis and severe acute pancreatitis (P 0.05), but severe acute pancreas and severe acute pancreatitis were in severe acute pancreatitis. There was no significant difference in hs-CRP in the group of sexual pancreatitis (P 0.05). The results of three groups of PCT, IL-6 and Ranson scores by Mann-whitney U test showed that PCT in severe acute pancreatitis group was significantly higher than that of mild acute pancreatitis and medium severe acute pancreas group, and the severe acute pancreas group was also significantly higher than that of mild acute pancreas. The difference was statistically significant (P 0.05).IL-6 results and hs-CRP consistent.Ranson score coincide with PCT. The three group CT grading by Kruskal-Wallis H test, the difference was statistically significant (P 0.05). The three groups of general data, including age, heart rate by statistical analysis, the three groups were statistically significant (P 0.05); mean arterial pressure The gender differences were not statistically significant (P 0.05). The hematology related indexes in the three groups, including neutrophils ratio (N%), blood calcium, leukocyte (WBC), blood glucose and LIPASE were statistically analyzed, the total difference between the three groups was statistically significant (P 0.05), and the total difference of AMY three groups was not statistically significant (P 0.05).2. was included in 104 patients. The proportion of severe and severe acute pancreatitis was about 48%. in order to obtain the accuracy and threshold value of PCT, hs-CRP, IL-6, Ranson score in the diagnosis of severe acute pancreatitis and severe acute pancreatitis (Receiver Operating Characteristic Curve, ROC). The results showed that the area under the curve of the four were: PCT (0). .948 + 0.020), hs-CRP (0.802 + 0.045), IL-6 (0.801 + 0.043), Ranson (0.980 + 0.014). The diagnostic thresholds for severe and severe acute pancreatitis were PCT (0.4825ng/ml), hs-CRP (91.69mg/l), IL-6 (74.25pg/ml), Ranson score (3.5), sensitivity (Sensitivity,%) and four (88) four (88) %, 88.9%), hs-CRP (86%, 70.4%), IL-6 (72%, 77.8%), Ranson (92%, 100%). Using PCT combined hs-CRP two thresholds combined determination analysis, the area under the curve is (0.945 + 0.021), the sensitivity and specificity are: (80%, 96.3%). The application of PCT combined with Ranson score and two threshold determination analysis, the area under the curve is: (0.997), sensitivity and specificity (100%, 96.3%).3. were included in 104 patients. The proportion of severe and severe acute pancreatitis was about 48%.PCT, hs-CRP, IL-6, and Ranson scores were positively correlated with the severity of acute pancreatitis. The results were PCT (r=0.839, P 0.001), hs-CRP (r= 0.531, P 0.001), IL-6 (0.001, 0.001). .PCT, hs-CRP, IL-6, Ranson scores were analyzed in four cases, all of which were positively correlated with 100 patients. There was no statistical difference in age, sex, and Ranson scores in the two groups. The length of antibiotics used in the.D group was long, and the length of hospitalization was (13.58 + 8.42, 15.52 + 6.25). The length of the antibiotics used in the E group and the length of the length of hospitalization (all the mean number) were respectively. (17.34 + 4.95, 22.68 + 6.14, day); group D, group E antibiotics used long, long through two independent samples t test, P 0.05. two antibiotics single use or combined use of x2 test, P 0.05.[conclusion]1.PCT, Ranson score, CT classification can be used as a criterion for judging the severity of acute pancreatitis, three values or scores. The higher the level of acute pancreatitis, the higher the severity of acute pancreatitis; IL-6, hs-CRP can be used as a reference index for the assessment of mild pancreatitis,.2. for severe and severe acute pancreatitis, the diagnostic threshold is PCT (0.4825ng/ml), hs-CRP (91.69mg/l), IL-6 (74.25pg/ml), Ranson score (3.5), and the diagnostic value for acute pancreatitis: PCT combined Ranson The score of Ranson score PCT PCT combined with hs-CRP hs-CRP IL-6, indicating that the combination of PCT and Ranson score is the best for the diagnosis of severe acute pancreatitis and severe acute pancreatitis. It shows that the combined diagnosis of the two cases is better than the diagnostic value of.PCT combined with hs-CRP two. 6, the Ranson score four was positively correlated with the severity of acute pancreatitis, and the 22 phase analysis between the four was also a positive correlation.4. dynamic monitoring PCT value as an effective reference index for the guidance of severe and severe acute pancreatitis in the treatment of antibiotics.
【學(xué)位授予單位】：昆明醫(yī)科大學(xué)
【學(xué)位級(jí)別】：碩士
【學(xué)位授予年份】：2017
【分類(lèi)號(hào)】：R576

【相似文獻(xiàn)】

相關(guān)期刊論文 前10條

1 何咪娜;黃其俊;;PCT在肺結(jié)核與非結(jié)核性肺部感染疾病鑒別中的意義[J];放射免疫學(xué)雜志;2012年03期

2 耿素敏;趙勇;吳晶;;血清HS-CRP在妊娠期高血壓疾病中的價(jià)值[J];中國(guó)誤診學(xué)雜志;2010年12期

3 黃偉萍;王世俊;;檢測(cè)PCT對(duì)新生兒高膽紅素血癥的病因分析和早期診斷的價(jià)值[J];中國(guó)優(yōu)生與遺傳雜志;2011年04期

4 丁詩(shī)文;;Hs-CRP與白細(xì)胞聯(lián)合檢測(cè)在小兒急性上呼吸道感染中的應(yīng)用[J];咸寧學(xué)院學(xué)報(bào)(醫(yī)學(xué)版);2012年01期

5 李彥彬;李貫緋;牛曉立;李麗;付鐵娟;;短暫性腦缺血發(fā)作患者血清Hs-CRP水平[J];中國(guó)老年學(xué)雜志;2013年18期

6 費(fèi)安興;;降鈣素原(PCT)在慢性重型乙型肝炎合并自發(fā)性細(xì)菌性腹膜炎中的臨床應(yīng)用價(jià)值[J];中國(guó)實(shí)驗(yàn)診斷學(xué);2013年09期

7 李林森;田金洲;蔡藝靈;時(shí)晶;邢亞楠;孫文軍;;136例急性腦梗死血瘀證與Hs-CRP血脂四項(xiàng)的相關(guān)性研究[J];遼寧中醫(yī)雜志;2010年09期

8 龔瑞瑩;劉明;龐永誠(chéng);鄧紅;;急性冠狀動(dòng)脈綜合征患者Hs-CRP、血脂和膽紅素的臨床研究[J];中國(guó)醫(yī)藥指南;2011年24期

9 胡瓊;;血清降鈣素原(PCT)測(cè)定在兒童細(xì)菌感染性疾病中的診斷意義[J];求醫(yī)問(wèn)藥(下半月);2013年10期

10 楊玲;;定量檢測(cè)全血Hs-CRP在監(jiān)測(cè)惡性腫瘤中的應(yīng)用[J];現(xiàn)代中西醫(yī)結(jié)合雜志;2012年06期

相關(guān)會(huì)議論文 前5條

1 李靈潔;;PCT程序中的國(guó)際初步審查[A];2014年中華全國(guó)專(zhuān)利代理人協(xié)會(huì)年會(huì)第五屆知識(shí)產(chǎn)權(quán)論壇論文（第三部分）[C];2014年

2 韓翻珍;;淺論P(yáng)CT申請(qǐng)國(guó)際階段優(yōu)先權(quán)的審查[A];2014年中華全國(guó)專(zhuān)利代理人協(xié)會(huì)年會(huì)第五屆知識(shí)產(chǎn)權(quán)論壇論文集（第一部分）[C];2014年

3 鹽田玲莉;;淺談PCT申請(qǐng)進(jìn)入韓國(guó)[A];2013年中華全國(guó)專(zhuān)利代理人協(xié)會(huì)年會(huì)暨第四屆知識(shí)產(chǎn)權(quán)論壇論文匯編第三部分[C];2013年

4 武利媛;;由一件涉及優(yōu)先權(quán)轉(zhuǎn)讓的PCT案例引發(fā)的思考[A];2014年中華全國(guó)專(zhuān)利代理人協(xié)會(huì)年會(huì)第五屆知識(shí)產(chǎn)權(quán)論壇論文（第三部分）[C];2014年

5 吳孟秋;陳蕊;;淺談PCT申請(qǐng)進(jìn)入歐洲地區(qū)階段的申請(qǐng)策略[A];2014年中華全國(guó)專(zhuān)利代理人協(xié)會(huì)年會(huì)第五屆知識(shí)產(chǎn)權(quán)論壇論文集（第一部分）[C];2014年

相關(guān)重要報(bào)紙文章 前3條

1 記者 麻毓筠;全市近三年向國(guó)外申請(qǐng)PCT專(zhuān)利不到20件[N];太原日?qǐng)?bào);2009年

2 記者 祝蕾　通訊員 仝連成;PCT專(zhuān)利去年申請(qǐng)34件[N];濟(jì)南日?qǐng)?bào);2011年

3 記者 崔靜思;海外專(zhuān)利布局論壇聚焦PCT策略[N];中國(guó)知識(shí)產(chǎn)權(quán)報(bào);2011年

相關(guān)碩士學(xué)位論文 前10條

1 計(jì)洋洋;PCT和hs-CRP、IL-6結(jié)合Ranson評(píng)分對(duì)急性胰腺炎嚴(yán)重程度評(píng)估價(jià)值及PCT指導(dǎo)其抗生素應(yīng)用的臨床研究[D];昆明醫(yī)科大學(xué);2017年

2 陳帥;高脂血癥性急性胰腺炎的臨床特征分析[D];山西醫(yī)科大學(xué);2017年

3 肖瑤;膿毒癥患兒急性期N末端腦鈉肽前體與PCT、Hs-CRP的相關(guān)性研究[D];昆明醫(yī)科大學(xué);2017年

4 武春苗;清下活血法對(duì)重癥急性胰腺炎大鼠肝損傷保護(hù)作用的機(jī)制研究[D];遼寧中醫(yī)藥大學(xué);2017年

5 孫國(guó)才;Hs-CRP與2型糖尿病患者認(rèn)知功能障礙的關(guān)系研究[D];青海大學(xué);2015年

6 孔令穎;門(mén)診COPD患者血清MCP-1、PCT、Hs-CRP水平及意義[D];河北醫(yī)科大學(xué);2016年

7 李雅芬;急性腦梗死患者早期血清中Hs-CRP、IL-6水平與卒中后抑郁的關(guān)系[D];山西醫(yī)科大學(xué);2017年

8 白露露;IL-33及sST2在急性胰腺炎合并急性腎損傷中的表達(dá)變化和作用[D];山西醫(yī)科大學(xué);2017年

9 張冠;血毒清保留灌腸治療膿毒癥的臨床觀察及其對(duì)PCT影響機(jī)制的探討[D];黑龍江中醫(yī)藥大學(xué);2011年

10 孫亞梅;雙歧三聯(lián)活菌膠囊對(duì)于實(shí)驗(yàn)性結(jié)腸炎小鼠腸及肝臟IL-6表達(dá)的影響[D];山西醫(yī)科大學(xué);2017年

，

本文編號(hào)：2150093